This is a Validated Antibody Database (VAD) review about dog KRT5, based on 58 published articles (read how Labome selects the articles), using KRT5 antibody in all methods. It is aimed to help Labome visitors find the most suited KRT5 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
KRT5 synonym: keratin, type II cytoskeletal 5

BioLegend
rabbit polyclonal (Poly19055)
  • immunohistochemistry - paraffin section; mouse; 1:2000; loading ...; fig 3c
BioLegend KRT5 antibody (BioLegend, PRB-160P) was used in immunohistochemistry - paraffin section on mouse samples at 1:2000 (fig 3c). Immunity (2018) ncbi
rabbit polyclonal (Poly19055)
  • western blot; mouse; 1:200; fig 6e
BioLegend KRT5 antibody (Covance, 905501) was used in western blot on mouse samples at 1:200 (fig 6e). Development (2018) ncbi
rabbit polyclonal (Poly19055)
  • immunohistochemistry - paraffin section; mouse; 1:200; loading ...; fig 3k
BioLegend KRT5 antibody (Covance, PRB-160P-100) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 3k). PLoS Genet (2017) ncbi
rabbit polyclonal (Poly19055)
  • immunohistochemistry; mouse; 1:250; loading ...; fig 1
In order to research the role for BMP4 i mouse ureter development, BioLegend KRT5 antibody (Covance, PRB-160P) was used in immunohistochemistry on mouse samples at 1:250 (fig 1). Hum Mol Genet (2017) ncbi
rabbit polyclonal (Poly19055)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig s1h
BioLegend KRT5 antibody (Covance, PRB-160P) was used in immunohistochemistry - paraffin section on mouse samples (fig s1h). Nature (2017) ncbi
rabbit polyclonal (Poly19055)
  • immunohistochemistry - paraffin section; mouse; 1:500; loading ...; fig s2c
In order to show that induction p53 loss in Krt8(+) mammary luminal cells leads to their clonal expansion without directly affecting their luminal identity, BioLegend KRT5 antibody (Covance, PRB-160P) was used in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig s2c). Nat Commun (2017) ncbi
rabbit polyclonal (Poly19055)
  • western blot; human; fig 5b
In order to determine the effects of repeated diacetyl vapor exposures on 3D organotypic cultures of human primary tracheobronchial epithelial cells, BioLegend KRT5 antibody (Covance, PRB160P) was used in western blot on human samples (fig 5b). J Proteome Res (2017) ncbi
rabbit polyclonal (Poly19055)
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 3c
In order to study the architecture of the mouse mammary gland using high-resolution 3D imaging, BioLegend KRT5 antibody (BioLegend, 905501) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 3c). Breast Cancer Res (2016) ncbi
rabbit polyclonal (Poly19055)
  • immunohistochemistry - paraffin section; human; loading ...; fig 4b
In order to study the effect of PIK3CA in breast cancer., BioLegend KRT5 antibody (Covance, PRB-160P) was used in immunohistochemistry - paraffin section on human samples (fig 4b). PLoS ONE (2016) ncbi
rabbit polyclonal (Poly19055)
  • immunohistochemistry; mouse; 1:2000; loading ...
In order to report how hedgehog signaling and stromal composition impact prostate cancer, BioLegend KRT5 antibody (Covance, PRB-160P) was used in immunohistochemistry on mouse samples at 1:2000. Dis Model Mech (2017) ncbi
rabbit polyclonal (Poly19055)
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; fig 5c
  • immunocytochemistry; human; 1:250; loading ...; fig 1c
In order to determine the role of 420 kinases in bi-lineage triple-negative breast cancer, BioLegend KRT5 antibody (Covance, PRB-160P) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 5c) and in immunocytochemistry on human samples at 1:250 (fig 1c). Oncotarget (2016) ncbi
rabbit polyclonal (Poly19055)
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 1b
In order to examine the differentiation potential of adult mammary stem cells, BioLegend KRT5 antibody (Covance, PRB160P) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 1b). Nat Commun (2016) ncbi
rabbit polyclonal (Poly19055)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 2d
In order to explore the interplay between p53 loss and Wnt/beta-catenin signaling in stem cell function and tumorigenesis, BioLegend KRT5 antibody (Covance, PRB-160P) was used in immunohistochemistry - paraffin section on mouse samples (fig 2d). Oncogene (2017) ncbi
rabbit polyclonal (Poly19055)
  • immunohistochemistry; mouse; 1:4000; fig 7
In order to examine TGFBR1 and TGFBR2 mutations in human vemurafenib-induced skin lesions and in sporadic cutaneous squamous cell carcinoma, BioLegend KRT5 antibody (Covance, AF138) was used in immunohistochemistry on mouse samples at 1:4000 (fig 7). Nat Commun (2016) ncbi
rabbit polyclonal (Poly19055)
  • immunohistochemistry - paraffin section; mouse; 1:2000; loading ...; fig 3c
BioLegend KRT5 antibody (Covance, PRB-160P) was used in immunohistochemistry - paraffin section on mouse samples at 1:2000 (fig 3c). Oncogene (2017) ncbi
rabbit polyclonal (Poly19055)
  • immunocytochemistry; human; 1:1000; loading ...; fig 2b
In order to propose that the NKX3.1-G9a-UTY transcriptional regulatory network is essential for prostate differentiation, BioLegend KRT5 antibody (Covance, PRB-160P) was used in immunocytochemistry on human samples at 1:1000 (fig 2b). Science (2016) ncbi
rabbit polyclonal (Poly19055)
  • flow cytometry; mouse; fig 2
BioLegend KRT5 antibody (covance, PRB-160P) was used in flow cytometry on mouse samples (fig 2). Stem Cell Reports (2016) ncbi
rabbit polyclonal (Poly19055)
  • immunohistochemistry; mouse; 1:500; fig 4
In order to determine how basal cell proliferation can be limited through an FGFR1-SPRY2 signaling axis in the steady-state airway epithelium, BioLegend KRT5 antibody (Covance, PRB-160P) was used in immunohistochemistry on mouse samples at 1:500 (fig 4). Dev Cell (2016) ncbi
rabbit polyclonal (Poly19055)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 1f
BioLegend KRT5 antibody (Covance, PRB-160P) was used in immunohistochemistry - paraffin section on mouse samples (fig 1f). Int J Biol Sci (2016) ncbi
rabbit polyclonal (Poly19055)
  • immunohistochemistry - paraffin section; mouse; 1:1000; fig 2
In order to study an increase in susceptibility of mice bladder cancer by conditional expression of the androgen receptor, BioLegend KRT5 antibody (Covance, PRB-160P) was used in immunohistochemistry - paraffin section on mouse samples at 1:1000 (fig 2). PLoS ONE (2016) ncbi
rabbit polyclonal (Poly19055)
  • immunohistochemistry - paraffin section; mouse; 1:1000; fig 2
BioLegend KRT5 antibody (Covance, PRB-160P) was used in immunohistochemistry - paraffin section on mouse samples at 1:1000 (fig 2). Development (2016) ncbi
rabbit polyclonal (Poly19055)
  • immunocytochemistry; mouse; 1:100; fig 3
BioLegend KRT5 antibody (Covance, PRB-160P) was used in immunocytochemistry on mouse samples at 1:100 (fig 3). Stem Cell Reports (2016) ncbi
rabbit polyclonal (Poly19055)
  • immunohistochemistry; mouse; 1:500; fig 7
BioLegend KRT5 antibody (Biolegend, PRB-160P) was used in immunohistochemistry on mouse samples at 1:500 (fig 7). Oncogene (2016) ncbi
rabbit polyclonal (Poly19055)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 2
  • immunocytochemistry; human; 1:100; loading ...; fig 4
BioLegend KRT5 antibody (Covance, PRB-160P-100) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 2) and in immunocytochemistry on human samples at 1:100 (fig 4). PLoS ONE (2015) ncbi
rabbit polyclonal (Poly19055)
  • immunohistochemistry - paraffin section; mouse; 1:1000; fig s2
In order to eluciate Scrib, polarity protein, that mediates epidermal development and supresses tumors during skin carcinogenesis, BioLegend KRT5 antibody (Covance, PRB-160P) was used in immunohistochemistry - paraffin section on mouse samples at 1:1000 (fig s2). Mol Cancer (2015) ncbi
rabbit polyclonal (Poly19055)
  • immunohistochemistry - paraffin section; mouse; 1:500; fig 2
BioLegend KRT5 antibody (Covance, PRB160P) was used in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig 2). Oncotarget (2015) ncbi
rabbit polyclonal (Poly19055)
  • immunohistochemistry - paraffin section; human; fig s5d
BioLegend KRT5 antibody (BAbCO, PRB-160P) was used in immunohistochemistry - paraffin section on human samples (fig s5d). Oncotarget (2015) ncbi
rabbit polyclonal (Poly19055)
  • immunohistochemistry - frozen section; mouse; 1:3000; fig 1
In order to investigate the contribution of Wnt/beta-catenin signaling to prostatic development and tumorigenesis, BioLegend KRT5 antibody (covance, PRB-160P) was used in immunohistochemistry - frozen section on mouse samples at 1:3000 (fig 1). Stem Cells (2015) ncbi
rabbit polyclonal (Poly19055)
  • immunohistochemistry - frozen section; mouse; 1:500; fig 1
BioLegend KRT5 antibody (Covance, PRB-160P) was used in immunohistochemistry - frozen section on mouse samples at 1:500 (fig 1). Cell Rep (2015) ncbi
rabbit polyclonal (Poly19055)
  • immunohistochemistry; mouse; 1:200; loading ...; fig 1b
BioLegend KRT5 antibody (Covance, PRB-160P) was used in immunohistochemistry on mouse samples at 1:200 (fig 1b). Oncogene (2016) ncbi
rabbit polyclonal (Poly19055)
  • immunohistochemistry - paraffin section; mouse; 1:50; fig 2
BioLegend KRT5 antibody (Covance, PRB-160P) was used in immunohistochemistry - paraffin section on mouse samples at 1:50 (fig 2). PLoS ONE (2015) ncbi
rabbit polyclonal (Poly19055)
  • western blot; rat
BioLegend KRT5 antibody (Covance, PRB-160P) was used in western blot on rat samples . Nat Cell Biol (2015) ncbi
rabbit polyclonal (Poly19055)
  • immunohistochemistry - paraffin section; mouse; fig s2
BioLegend KRT5 antibody (Covance, PRB-160P) was used in immunohistochemistry - paraffin section on mouse samples (fig s2). Cancer Res (2015) ncbi
rabbit polyclonal (Poly19055)
  • immunohistochemistry; human; fig 3
In order to analyze the contribution of genetic alterations and cell type of origin in breast cancer phenotypes, BioLegend KRT5 antibody (Covance, PRB-160P) was used in immunohistochemistry on human samples (fig 3). Oncotarget (2015) ncbi
rabbit polyclonal (Poly19055)
  • immunocytochemistry; mouse; 1:1000
In order to identify G-protein-coupled receptor 5 (Lgr5) expression in prostate epithelial progenitor cells, BioLegend KRT5 antibody (Covance, PRB-160P) was used in immunocytochemistry on mouse samples at 1:1000. Stem Cell Reports (2015) ncbi
rabbit polyclonal (Poly19055)
  • immunohistochemistry - paraffin section; mouse; 1:800; fig 4
In order to elucidate role of androgen signaling in beta-catenin-initiated prostate tumorigenesis, BioLegend KRT5 antibody (Covance, PRB-160P) was used in immunohistochemistry - paraffin section on mouse samples at 1:800 (fig 4). Oncogene (2016) ncbi
rabbit polyclonal (Poly19055)
  • immunohistochemistry; mouse
  • immunohistochemistry; human
BioLegend KRT5 antibody (Covance, PRB-160P) was used in immunohistochemistry on mouse samples and in immunohistochemistry on human samples . Eur J Immunol (2015) ncbi
rabbit polyclonal (Poly19055)
  • immunohistochemistry - paraffin section; mouse; 1:5000; fig 4
BioLegend KRT5 antibody (Covance, PRB-160P) was used in immunohistochemistry - paraffin section on mouse samples at 1:5000 (fig 4). J Cell Biol (2015) ncbi
rabbit polyclonal (Poly19055)
  • immunohistochemistry - paraffin section; mouse; fig 5
In order to analyze mouse papillomavirus (MmuPV1) induction of endophytic trichoblastomas and exophytic papillomas for strain background, immune status, and anatomic site of inoculation, BioLegend KRT5 antibody (Covance, PRB-160P) was used in immunohistochemistry - paraffin section on mouse samples (fig 5). PLoS ONE (2014) ncbi
rabbit polyclonal (Poly19055)
  • immunohistochemistry - paraffin section; mouse
BioLegend KRT5 antibody (Covance, PRB-160P) was used in immunohistochemistry - paraffin section on mouse samples . Cancer Res (2014) ncbi
rabbit polyclonal (Poly19055)
  • immunohistochemistry - paraffin section; mouse; fig 5
In order to determine requirement for steroid receptor coactivator-3 in developing neuroendocrine tumor in the mouse prostate, BioLegend KRT5 antibody (Covance, PRB160P) was used in immunohistochemistry - paraffin section on mouse samples (fig 5). Int J Biol Sci (2014) ncbi
rabbit polyclonal (Poly19055)
  • immunocytochemistry; mouse
In order to investigate the role of FoxN1 during T and B lymphopoiesis in juvenile mice, BioLegend KRT5 antibody (Covance, PRB-160P) was used in immunocytochemistry on mouse samples . Cell Death Dis (2014) ncbi
rabbit polyclonal (Poly19055)
  • immunohistochemistry - paraffin section; human
BioLegend KRT5 antibody (Covance, PRB-160P) was used in immunohistochemistry - paraffin section on human samples . J Cutan Pathol (2014) ncbi
rabbit polyclonal (Poly19055)
  • immunohistochemistry - paraffin section; mouse; 1:400
BioLegend KRT5 antibody (Covance, PRB-160P) was used in immunohistochemistry - paraffin section on mouse samples at 1:400. PLoS ONE (2014) ncbi
rabbit polyclonal (Poly19055)
  • immunohistochemistry - paraffin section; mouse; 1:400
In order to assess the contribution of Tbx1 to thymus and parathyroid development, BioLegend KRT5 antibody (Covance, PRB-160P-100) was used in immunohistochemistry - paraffin section on mouse samples at 1:400. Development (2014) ncbi
rabbit polyclonal (Poly19055)
  • immunohistochemistry - paraffin section; human; 1:500
In order to study the role of BMP in mammary cancer, BioLegend KRT5 antibody (Covance, PRB-160P-100) was used in immunohistochemistry - paraffin section on human samples at 1:500. Oncogene (2015) ncbi
rabbit polyclonal (Poly19055)
  • immunohistochemistry - paraffin section; mouse; 1:1000
In order to develop a small animal model to study orthotopic tracheal transplantation, BioLegend KRT5 antibody (Covance, PRB-160P) was used in immunohistochemistry - paraffin section on mouse samples at 1:1000. Tissue Eng Part A (2015) ncbi
rabbit polyclonal (Poly19055)
  • western blot; rabbit
  • western blot; mouse
BioLegend KRT5 antibody (Covance, PRB-160P) was used in western blot on rabbit samples and in western blot on mouse samples . Nat Commun (2014) ncbi
rabbit polyclonal (Poly19055)
  • immunohistochemistry - paraffin section; mouse
BioLegend KRT5 antibody (Covance, PRB-160P) was used in immunohistochemistry - paraffin section on mouse samples . PLoS Genet (2014) ncbi
rabbit polyclonal (Poly19055)
  • immunohistochemistry; mouse; 1:1000
BioLegend KRT5 antibody (Covance Lab, PRB-160P) was used in immunohistochemistry on mouse samples at 1:1000. Endocr Relat Cancer (2014) ncbi
rabbit polyclonal (Poly19055)
  • immunohistochemistry - frozen section; mouse; 1:1000
BioLegend KRT5 antibody (Covance, PRB-160P) was used in immunohistochemistry - frozen section on mouse samples at 1:1000. J Cell Biol (2013) ncbi
rabbit polyclonal (Poly19055)
  • immunohistochemistry; mouse
In order to study the induction of inflammation, metaplasia and displasia following transgenic expression of IFN-gamma in the murine stomach, BioLegend KRT5 antibody (Covance, PRB-160P) was used in immunohistochemistry on mouse samples . Am J Pathol (2012) ncbi
rabbit polyclonal (Poly19055)
  • immunocytochemistry; human; 1:15000
BioLegend KRT5 antibody (Covance, PRB-160P) was used in immunocytochemistry on human samples at 1:15000. Am J Pathol (2012) ncbi
Invitrogen
mouse monoclonal (AE3)
  • flow cytometry; human; loading ...
In order to examine epithelial cell populations from touch samples, Invitrogen KRT5 antibody (eBioscience, 14-900-80) was used in flow cytometry on human samples . F1000Res (2016) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; mouse; 1:100; loading ...; tbl 2
In order to investigate if conditioned medium from proliferating fibroblasts induce a subset of hematopoietic cells to become adherent fibroblast-like cells, Invitrogen KRT5 antibody (eBioscience, 41-9003) was used in immunocytochemistry on mouse samples at 1:100 (tbl 2). J Cell Physiol (2016) ncbi
mouse monoclonal (AE1/AE3)
  • flow cytometry; human
  • immunocytochemistry; human; 1 ul
Invitrogen KRT5 antibody (eBioscience, 53-9003-82) was used in flow cytometry on human samples and in immunocytochemistry on human samples at 1 ul. Nanomedicine (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:200; fig 3
In order to study juxtacrine signaling from macrophages and monocytes and a breast cancer stem cell niche, Invitrogen KRT5 antibody (eBioscience, 53-9003-80) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 3). Nat Cell Biol (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; human; 1:100; fig 1
Invitrogen KRT5 antibody (eBioscience, AE1/AE3) was used in immunocytochemistry on human samples at 1:100 (fig 1). PLoS ONE (2013) ncbi
Articles Reviewed
  1. Mollaoglu G, Jones A, Wait S, Mukhopadhyay A, Jeong S, Arya R, et al. The Lineage-Defining Transcription Factors SOX2 and NKX2-1 Determine Lung Cancer Cell Fate and Shape the Tumor Immune Microenvironment. Immunity. 2018;49:764-779.e9 pubmed publisher
  2. Tucker A, Dyer C, Fons Romero J, Teshima T, Fuchs J, Thompson H. Mapping the distribution of stem/progenitor cells across the mouse middle ear during homeostasis and inflammation. Development. 2018;145: pubmed publisher
  3. He H, Huang M, Sun S, Wu Y, Lin X. Epithelial heparan sulfate regulates Sonic Hedgehog signaling in lung development. PLoS Genet. 2017;13:e1006992 pubmed publisher
  4. Mamo T, Wittern A, Kleppa M, Bohnenpoll T, Weiss A, Kispert A. BMP4 uses several different effector pathways to regulate proliferation and differentiation in the epithelial and mesenchymal tissue compartments of the developing mouse ureter. Hum Mol Genet. 2017;26:3553-3563 pubmed publisher
  5. Lu X, Horner J, Paul E, Shang X, Troncoso P, Deng P, et al. Effective combinatorial immunotherapy for castration-resistant prostate cancer. Nature. 2017;543:728-732 pubmed publisher
  6. Tao L, Xiang D, Xie Y, Bronson R, Li Z. Induced p53 loss in mouse luminal cells causes clonal expansion and development of mammary tumours. Nat Commun. 2017;8:14431 pubmed publisher
  7. Kwon Y, Stanciu C, Philpott M, Ehrhardt C. Flow cytometry dataset for cells collected from touched surfaces. F1000Res. 2016;5:390 pubmed publisher
  8. Foster M, Gwinn W, Kelly F, Brass D, Valente A, Moseley M, et al. Proteomic Analysis of Primary Human Airway Epithelial Cells Exposed to the Respiratory Toxicant Diacetyl. J Proteome Res. 2017;16:538-549 pubmed publisher
  9. Lloyd Lewis B, Davis F, Harris O, Hitchcock J, Lourenco F, Pasche M, et al. Imaging the mammary gland and mammary tumours in 3D: optical tissue clearing and immunofluorescence methods. Breast Cancer Res. 2016;18:127 pubmed
  10. Bhagirath D, Zhao X, Mirza S, West W, Band H, Band V. Mutant PIK3CA Induces EMT in a Cell Type Specific Manner. PLoS ONE. 2016;11:e0167064 pubmed publisher
  11. Yang Z, Peng Y, Gopalan A, Gao D, Chen Y, Joyner A. Stromal hedgehog signaling maintains smooth muscle and hampers micro-invasive prostate cancer. Dis Model Mech. 2017;10:39-52 pubmed publisher
  12. Strietz J, Stepputtis S, Preca B, Vannier C, Kim M, Castro D, et al. ERN1 and ALPK1 inhibit differentiation of bi-potential tumor-initiating cells in human breast cancer. Oncotarget. 2016;7:83278-83293 pubmed publisher
  13. Davis F, Lloyd Lewis B, Harris O, Kozar S, Winton D, Muresan L, et al. Single-cell lineage tracing in the mammary gland reveals stochastic clonal dispersion of stem/progenitor cell progeny. Nat Commun. 2016;7:13053 pubmed publisher
  14. Chiche A, Moumen M, Romagnoli M, Petit V, Lasla H, Jézéquel P, et al. p53 deficiency induces cancer stem cell pool expansion in a mouse model of triple-negative breast tumors. Oncogene. 2017;36:2355-2365 pubmed publisher
  15. Cammareri P, Rose A, Vincent D, Wang J, Nagano A, Libertini S, et al. Inactivation of TGFβ receptors in stem cells drives cutaneous squamous cell carcinoma. Nat Commun. 2016;7:12493 pubmed publisher
  16. Su Q, Zhang B, Zhang L, Dang T, Rowley D, Ittmann M, et al. Jagged1 upregulation in prostate epithelial cells promotes formation of reactive stroma in the Pten null mouse model for prostate cancer. Oncogene. 2017;36:618-627 pubmed publisher
  17. Dutta A, Le Magnen C, Mitrofanova A, Ouyang X, Califano A, Abate Shen C. Identification of an NKX3.1-G9a-UTY transcriptional regulatory network that controls prostate differentiation. Science. 2016;352:1576-80 pubmed publisher
  18. Wang N, Dong B, Quan Y, Chen Q, Chu M, Xu J, et al. Regulation of Prostate Development and Benign Prostatic Hyperplasia by Autocrine Cholinergic Signaling via Maintaining the Epithelial Progenitor Cells in Proliferating Status. Stem Cell Reports. 2016;6:668-678 pubmed publisher
  19. Balasooriya G, Johnson J, Basson M, Rawlins E. An FGFR1-SPRY2 Signaling Axis Limits Basal Cell Proliferation in the Steady-State Airway Epithelium. Dev Cell. 2016;37:85-97 pubmed publisher
  20. Holloway K, Sinha V, Bu W, Toneff M, Dong J, Peng Y, et al. Targeting Oncogenes into a Defined Subset of Mammary Cells Demonstrates That the Initiating Oncogenic Mutation Defines the Resulting Tumor Phenotype. Int J Biol Sci. 2016;12:381-8 pubmed publisher
  21. Johnson D, Hooker E, Luong R, Yu E, He Y, Gonzalgo M, et al. Conditional Expression of the Androgen Receptor Increases Susceptibility of Bladder Cancer in Mice. PLoS ONE. 2016;11:e0148851 pubmed publisher
  22. Tadokoro T, Gao X, Hong C, Hotten D, Hogan B. BMP signaling and cellular dynamics during regeneration of airway epithelium from basal progenitors. Development. 2016;143:764-73 pubmed publisher
  23. Maimets M, Rocchi C, Bron R, Pringle S, Kuipers J, Giepmans B, et al. Long-Term In Vitro Expansion of Salivary Gland Stem Cells Driven by Wnt Signals. Stem Cell Reports. 2016;6:150-62 pubmed publisher
  24. Li Y, Adomat H, Guns E, Hojabrpour P, Duronio V, Curran T, et al. Identification of a Hematopoietic Cell Dedifferentiation-Inducing Factor. J Cell Physiol. 2016;231:1350-63 pubmed publisher
  25. Wang Z, Kim J, Teng Y, Ding H, Zhang J, Hai T, et al. Loss of ATF3 promotes hormone-induced prostate carcinogenesis and the emergence of CK5(+)CK8(+) epithelial cells. Oncogene. 2016;35:3555-64 pubmed publisher
  26. Abou Kheir W, Eid A, El Merahbi R, Assaf R, Daoud G. A Unique Expression of Keratin 14 in a Subset of Trophoblast Cells. PLoS ONE. 2015;10:e0139939 pubmed publisher
  27. Pearson H, McGlinn E, Phesse T, Schlüter H, Srikumar A, Gödde N, et al. The polarity protein Scrib mediates epidermal development and exerts a tumor suppressive function during skin carcinogenesis. Mol Cancer. 2015;14:169 pubmed publisher
  28. Pickup M, Hover L, Guo Y, Gorska A, Chytil A, Novitskiy S, et al. Deletion of the BMP receptor BMPR1a impairs mammary tumor formation and metastasis. Oncotarget. 2015;6:22890-904 pubmed
  29. Liu X, Chen X, Rycaj K, Chao H, Deng Q, Jeter C, et al. Systematic dissection of phenotypic, functional, and tumorigenic heterogeneity of human prostate cancer cells. Oncotarget. 2015;6:23959-86 pubmed
  30. Lee S, Johnson D, Luong R, Yu E, Cunha G, Nusse R, et al. Wnt/β-Catenin-Responsive Cells in Prostatic Development and Regeneration. Stem Cells. 2015;33:3356-67 pubmed publisher
  31. Watson J, Rulands S, Wilkinson A, Wuidart A, Ousset M, Van Keymeulen A, et al. Clonal Dynamics Reveal Two Distinct Populations of Basal Cells in Slow-Turnover Airway Epithelium. Cell Rep. 2015;12:90-101 pubmed publisher
  32. Hein S, Haricharan S, Johnston A, Toneff M, Reddy J, Dong J, et al. Luminal epithelial cells within the mammary gland can produce basal cells upon oncogenic stress. Oncogene. 2016;35:1461-7 pubmed publisher
  33. Lokody I, Francis J, Gardiner J, Erler J, Swain A. Pten Regulates Epithelial Cytodifferentiation during Prostate Development. PLoS ONE. 2015;10:e0129470 pubmed publisher
  34. Muhanna N, Mepham A, Mohamadi R, Chan H, Khan T, Akens M, et al. Nanoparticle-based sorting of circulating tumor cells by epithelial antigen expression during disease progression in an animal model. Nanomedicine. 2015;11:1613-20 pubmed publisher
  35. Iglesias Bartolomé R, Torres D, Marone R, Feng X, Martin D, Simaan M, et al. Inactivation of a Gα(s)-PKA tumour suppressor pathway in skin stem cells initiates basal-cell carcinogenesis. Nat Cell Biol. 2015;17:793-803 pubmed publisher
  36. Ruscetti M, Quach B, Dadashian E, Mulholland D, Wu H. Tracking and Functional Characterization of Epithelial-Mesenchymal Transition and Mesenchymal Tumor Cells during Prostate Cancer Metastasis. Cancer Res. 2015;75:2749-59 pubmed publisher
  37. Bhagirath D, Zhao X, West W, Qiu F, Band H, Band V. Cell type of origin as well as genetic alterations contribute to breast cancer phenotypes. Oncotarget. 2015;6:9018-30 pubmed
  38. Wang B, Wang X, Long J, Eastham Anderson J, Firestein R, Junttila M. Castration-resistant Lgr5(+) cells are long-lived stem cells required for prostatic regeneration. Stem Cell Reports. 2015;4:768-79 pubmed publisher
  39. Lee S, Luong R, Johnson D, Cunha G, Rivina L, Gonzalgo M, et al. Androgen signaling is a confounding factor for β-catenin-mediated prostate tumorigenesis. Oncogene. 2016;35:702-14 pubmed publisher
  40. Franckaert D, Schlenner S, Heirman N, Gill J, Skogberg G, Ekwall O, et al. Premature thymic involution is independent of structural plasticity of the thymic stroma. Eur J Immunol. 2015;45:1535-47 pubmed publisher
  41. Roarty K, Shore A, Creighton C, Rosen J. Ror2 regulates branching, differentiation, and actin-cytoskeletal dynamics within the mammary epithelium. J Cell Biol. 2015;208:351-66 pubmed publisher
  42. Sundberg J, Stearns T, Joh J, Proctor M, Ingle A, Silva K, et al. Immune status, strain background, and anatomic site of inoculation affect mouse papillomavirus (MmuPV1) induction of exophytic papillomas or endophytic trichoblastomas. PLoS ONE. 2014;9:e113582 pubmed publisher
  43. Sicoli D, Jiao X, Ju X, Velasco Velázquez M, Ertel A, Addya S, et al. CCR5 receptor antagonists block metastasis to bone of v-Src oncogene-transformed metastatic prostate cancer cell lines. Cancer Res. 2014;74:7103-14 pubmed publisher
  44. Tien J, Liao L, Liu Y, Liu Z, Lee D, Wang F, et al. The steroid receptor coactivator-3 is required for developing neuroendocrine tumor in the mouse prostate. Int J Biol Sci. 2014;10:1116-27 pubmed publisher
  45. Ruan L, Zhang Z, Mu L, BURNLEY P, Wang L, Coder B, et al. Biological significance of FoxN1 gain-of-function mutations during T and B lymphopoiesis in juvenile mice. Cell Death Dis. 2014;5:e1457 pubmed publisher
  46. Lu H, Clauser K, Tam W, Fröse J, Ye X, Eaton E, et al. A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages. Nat Cell Biol. 2014;16:1105-17 pubmed publisher
  47. O Shea C, Fitzpatrick J, Koch P. Desmosomal defects in acantholytic squamous cell carcinomas. J Cutan Pathol. 2014;41:873-9 pubmed publisher
  48. Chibly A, Querin L, Harris Z, Limesand K. Label-retaining cells in the adult murine salivary glands possess characteristics of adult progenitor cells. PLoS ONE. 2014;9:e107893 pubmed publisher
  49. Reeh K, Cardenas K, Bain V, Liu Z, LAURENT M, Manley N, et al. Ectopic TBX1 suppresses thymic epithelial cell differentiation and proliferation during thymus organogenesis. Development. 2014;141:2950-8 pubmed publisher
  50. Owens P, Pickup M, Novitskiy S, Giltnane J, Gorska A, Hopkins C, et al. Inhibition of BMP signaling suppresses metastasis in mammary cancer. Oncogene. 2015;34:2437-49 pubmed publisher
  51. Kutten J, McGovern D, Hobson C, Luffy S, Nieponice A, Tobita K, et al. Decellularized tracheal extracellular matrix supports epithelial migration, differentiation, and function. Tissue Eng Part A. 2015;21:75-84 pubmed publisher
  52. Piazzolla D, Palla A, Pantoja C, Canamero M, de Castro I, Ortega S, et al. Lineage-restricted function of the pluripotency factor NANOG in stratified epithelia. Nat Commun. 2014;5:4226 pubmed publisher
  53. Godde N, Sheridan J, Smith L, Pearson H, Britt K, Galea R, et al. Scribble modulates the MAPK/Fra1 pathway to disrupt luminal and ductal integrity and suppress tumour formation in the mammary gland. PLoS Genet. 2014;10:e1004323 pubmed publisher
  54. Assefnia S, Kang K, Groeneveld S, Yamaji D, Dabydeen S, Alamri A, et al. Trp63 is regulated by STAT5 in mammary tissue and subject to differentiation in cancer. Endocr Relat Cancer. 2014;21:443-57 pubmed publisher
  55. Lafkas D, Rodilla V, Huyghe M, Mourao L, Kiaris H, Fre S. Notch3 marks clonogenic mammary luminal progenitor cells in vivo. J Cell Biol. 2013;203:47-56 pubmed publisher
  56. Hosokawa M, Kenmotsu H, Koh Y, Yoshino T, Yoshikawa T, Naito T, et al. Size-based isolation of circulating tumor cells in lung cancer patients using a microcavity array system. PLoS ONE. 2013;8:e67466 pubmed publisher
  57. Syu L, El Zaatari M, Eaton K, Liu Z, Tetarbe M, Keeley T, et al. Transgenic expression of interferon-? in mouse stomach leads to inflammation, metaplasia, and dysplasia. Am J Pathol. 2012;181:2114-25 pubmed publisher
  58. Pellakuru L, Iwata T, Gurel B, Schultz D, Hicks J, Bethel C, et al. Global levels of H3K27me3 track with differentiation in vivo and are deregulated by MYC in prostate cancer. Am J Pathol. 2012;181:560-9 pubmed publisher